Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q1 2023
- Shares held
- 70.3M
- +3.45M (+5.2%) vs. Q1 2023
- Total value
- $435.4M
- +$177.9M (+69.1%) vs. Q1 2023
- New holders
- 5
- 15 more added
- Sold out
- 4
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 38 | $0 | 0.00% | +38 | New |
| Daiwa Securities Group Inc. | 211 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 185 | $1.00K | 0.00% | +115+164.3% | Added |
| China Universal Asset Management Co., Ltd. | 691 | $4.28K | 0.00% | −21−2.9% | Reduced |
| Global Retirement Partners, LLC | 700 | $4.33K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 895 | $5.54K | 0.00% | +294+48.9% | Added |
| Adirondack Trust Co | 925 | $7.31K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,118 | $13.1K | 0.00% | −3,045−59.0% | Reduced |
| Advisor Group Holdings, Inc. | 3,176 | $19.7K | 0.00% | +431+15.7% | Added |
| Citadel Advisors LLC | 4,105 | $25.4K | 0.00% | +4,105 | New |
| Bank of America Corp | 4,211 | $26.1K | 0.00% | +2,926+227.7% | Added |
| Tower Research Capital LLC (TRC) | 4,272 | $26.4K | 0.00% | −4,302−50.2% | Reduced |
| Compagnie Lombard Odier SCmA | 5,820 | $36.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,400 | $39.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 10,650 | $65.9K | 0.00% | −310−2.8% | Reduced |
| Two Sigma Investments, LP | 11,100 | $68.7K | 0.00% | +11,100 | New |
| Geode Capital Management, LLC | 25,120 | $155.5K | 0.00% | +2,434+10.7% | Added |
| Renaissance Technologies LLC | 34,300 | $212.0K | 0.00% | +18,600+118.5% | Added |
| Manufacturers Life Insurance Company, The | 57,421 | $355.4K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 59,364 | $367.5K | 0.00% | −39,861−40.2% | Reduced |
| TD Asset Management Inc | 82,055 | $507.9K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 125,157 | $774.7K | 0.00% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 171,625 | $1.06M | 0.04% | +171,625 | New |
| BlackRock Inc. | 294,500 | $1.82M | 0.00% | +1,840+0.6% | Added |
| Octagon Capital Advisors LP | 411,928 | $2.55M | 0.36% | +15,928+4.0% | Added |
| Cormorant Asset Management, LP | 561,600 | $3.48M | 0.20% | 00.0% | Unchanged |
| Woodline Partners LP | 687,763 | $4.26M | 0.05% | −48,230−6.6% | Reduced |
| American Century Companies Inc | 694,862 | $4.30M | 0.00% | +180,746+35.2% | Added |
| Tanager Wealth Management LLP | 696,096 | $4.31M | 0.93% | −40,963−5.6% | Reduced |
| Kynam Capital Management, LP | 729,077 | $4.51M | 0.69% | 00.0% | Unchanged |
| Morgan Stanley | 824,629 | $5.10M | 0.00% | +80,722+10.9% | Added |
| Franklin Resources Inc | 832,348 | $5.15M | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 877,193 | $5.43M | 1.92% | +529,324+152.2% | Added |
| Affinity Asset Advisors, LLC | 900,723 | $5.58M | 2.19% | +216,596+31.7% | Added |
| Boxer Capital, LLC | 1,251,137 | $7.75M | 0.36% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,011,388 | $12.5M | 0.04% | +235,906+13.3% | Added |
| Adage Capital Partners GP, L.L.C. | 2,250,000 | $13.9M | 0.03% | +2,250,000 | New |
| Price T Rowe Associates Inc | 2,363,211 | $14.6M | 0.00% | +49,778+2.2% | Added |
| FMR LLC | 2,787,194 | $17.3M | 0.00% | +1,556,285+126.4% | Added |
| OUP Management Co., LLC | 2,937,615 | $18.2M | 31.01% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 3,931,818 | $24.3M | 31.78% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,618,779 | $34.8M | 0.92% | 00.0% | Unchanged |
| BVF Inc | 9,423,215 | $58.3M | 1.63% | 00.0% | Unchanged |
| General Atlantic LLC | 9,681,818 | $59.9M | 0.94% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $123.6M | 34.62% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −1,693,736−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,238−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,616−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −220−100.0% | Sold out |